Cranial and Auricular Neuromodulation 1.01.58
Summary
New policy 1.01.58 with an effective date of May 21, 2026 classifies several cranial and auricular neuromodulation methods as investigational. The investigational methods are cranial electrical stimulation, external trigeminal nerve stimulation (Monarch), transcutaneous non-implantable vagus nerve stimulation (gammaCore Sapphire), transcutaneous supraorbital neurostimulation (Cefaly), and auricular electrostimulation, including percutaneous electrical nerve field stimulation (PENFS) such as P-Stim, IB-Stim and NSS-2 Bridge. The policy does not address cranial electrotherapy stimulation for the treatment of behavioral health conditions, or implantable vagus nerve stimulation and vagus nerve blocking therapy.
Get alerts when payers change rules like this one
We check Excellus BlueCross BlueShield and other payers every day and email you when a change matches your specialty and state.